Nuformix (NFX.L) Stock Price
£0.093 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
1 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Nuformix, AI stock picks, stock alerts and much more.
NFX.L AI Stock Analysis
AI stock analysis for NFX.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Nuformix (NFX.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Nuformix (NFX.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Nuformix (NFX.L), currently trading at £0.093, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About NFX.L
-
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.
-
Symbol
NFX.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
1.8M
Similar Stocks
 |
Codexis 0I0X.L |
$3.01 0.7% |
5 |
 |
Oxford Nanopore Technologies plc ONT.L |
£209.8 0.3% |
7 |
 |
Sareum Holdings SAR.L |
£23 18% |
5 |
 |
Viridian Therapeutics 0K1R.L |
$18.21 3% |
6 |
 |
Avacta Group Plc AVCT.L |
£50.7 5.6% |
4 |
News
NFX.L Alternative Data
Web Traffic
Nuformix receives an estimated 244 monthly visitors to nuformix.com.
-
Web Traffic
244
-
Change from Previous Month
106.8%
-
3 Month Change
0%
-
YoY Change
0%
Twitter Followers
Nuformix has 402 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.5% over the last month.
-
Twitter Followers
402
-
Daily Change
0.2%
-
1 Month Change
1.5%
-
3 Month Change
1.5%
-
YoY Change
1.5%
Youtube Subscribers
Nuformix has 12 subscribers on its main Youtube channel.
-
Youtube Subscribers
12
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Job Postings
Nuformix currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Nuformix has 4 employees, down by -20% over the last month.
-
LinkedIn Employees
4
-
Daily Change
20%
-
1 Month Change
20%
-
3 Month Change
20%
-
YoY Change
20%
News Mentions
Nuformix was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Nuformix has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
NFX.L Financials
NFX.L Key Metrics
-
Total Revenue
£0
-
Net Income
-£242.5K
-
Earnings per Share
-£0.0003
-
Free cash flow
-£168.6K
-
EBITDA
-£234K
-
EBITDA Ratio
0
-
Total Assets
£970.5K
NFX.L 2-year Revenue & Income
NFX.L 2-year Free Cash Flow
NFX.L Technicals
NFX.L SMA
NFX.L RSI
FAQ
What's the current price of Nuformix (NFX.L) Stock?
The price of an Nuformix (NFX.L) share is £0.093.
What's the market cap of Nuformix?
The current market cap of Nuformix is 1.8M.
Should I buy or sell NFX.L?
Nuformix shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Nuformix is better viewed as a hold or accumulate position while waiting for further developments.
Is Nuformix a good investment?
The current analysis of Nuformix's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Nuformix's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Nuformix (NFX.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Nuformix stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Nuformix (NFX.L) that investors often compare it to?
Nuformix (NFX.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.
What is the forecast for Nuformix's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Nuformix's stock price to be around £0.093 in 2026. Starting from the current price of £0.093, this represents a 0% change in price, indicating a neutral outlook for the stock.
How to buy Nuformix (NFX.L) Stock?
Nuformix stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Nuformix shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.